Exact Mass: 495.1965
Exact Mass Matches: 495.1965
Found 200 metabolites which its exact mass value is equals to given mass value 495.1965
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Isometamidium chloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Ala Tyr Asn Glu
Thr Asn Phe Asp
Ala Asp Gln Tyr
Ala Asp Tyr Gln
Ala Glu Asn Tyr
Ala Glu Tyr Asn
Ala Asn Glu Tyr
Ala Asn Tyr Glu
Ala Gln Asp Tyr
Ala Gln Tyr Asp
Ala Tyr Asp Gln
Ala Tyr Glu Asn
Ala Tyr Gln Asp
Cys Met Arg Ser
Cys Met Ser Arg
Cys Arg Met Ser
Cys Arg Ser Met
Cys Ser Met Arg
Cys Ser Arg Met
Asp Ala Gln Tyr
Asp Ala Tyr Gln
Asp Phe Asn Thr
Asp Phe Gln Ser
Asp Phe Ser Gln
Asp Phe Thr Asn
Asp Asn Phe Thr
Asp Asn Thr Phe
Asp Gln Ala Tyr
Asp Gln Phe Ser
Asp Gln Ser Phe
Asp Gln Tyr Ala
Asp Ser Phe Gln
Asp Ser Gln Phe
Asp Thr Phe Asn
Asp Thr Asn Phe
Asp Tyr Ala Gln
Asp Tyr Gln Ala
Glu Ala Asn Tyr
Glu Ala Tyr Asn
Glu Phe Asn Ser
Glu Phe Ser Asn
Glu Gly Gln Tyr
Glu Gly Tyr Gln
Glu Asn Ala Tyr
Glu Asn Phe Ser
Glu Asn Ser Phe
Glu Asn Tyr Ala
Glu Gln Gly Tyr
Glu Gln Tyr Gly
Glu Ser Phe Asn
Glu Ser Asn Phe
Glu Tyr Ala Asn
Glu Tyr Gly Gln
Glu Tyr Asn Ala
Glu Tyr Gln Gly
Phe Asp Asn Thr
Phe Asp Gln Ser
Phe Asp Ser Gln
Phe Asp Thr Asn
Phe Glu Asn Ser
Phe Glu Ser Asn
Phe Asn Asp Thr
Phe Asn Glu Ser
Phe Asn Ser Glu
Phe Asn Thr Asp
Phe Gln Asp Ser
Phe Gln Ser Asp
Phe Ser Asp Gln
Phe Ser Glu Asn
Phe Ser Asn Glu
Phe Ser Gln Asp
Phe Thr Asp Asn
Phe Thr Asn Asp
Gly Glu Gln Tyr
Gly Glu Tyr Gln
Gly Gln Glu Tyr
Gly Gln Tyr Glu
Gly Tyr Glu Gln
Gly Tyr Gln Glu
Met Cys Arg Ser
Met Cys Ser Arg
Met Arg Cys Ser
Met Arg Ser Cys
Met Ser Cys Arg
Met Ser Arg Cys
Asn Ala Glu Tyr
Asn Ala Tyr Glu
Asn Asp Phe Thr
Asn Asp Thr Phe
Asn Glu Ala Tyr
Asn Glu Phe Ser
Asn Glu Ser Phe
Asn Glu Tyr Ala
Asn Phe Asp Thr
Asn Phe Glu Ser
Asn Phe Ser Glu
Asn Phe Thr Asp
Asn Ser Glu Phe
Asn Ser Phe Glu
Asn Thr Asp Phe
Asn Thr Phe Asp
Asn Tyr Ala Glu
Asn Tyr Glu Ala
Gln Ala Asp Tyr
Gln Ala Tyr Asp
Gln Asp Ala Tyr
Gln Asp Phe Ser
Gln Asp Ser Phe
Gln Asp Tyr Ala
Gln Glu Gly Tyr
Gln Glu Tyr Gly
Gln Phe Asp Ser
Gln Phe Ser Asp
Gln Gly Glu Tyr
Gln Gly Tyr Glu
Gln Ser Asp Phe
Gln Ser Phe Asp
Gln Tyr Ala Asp
Gln Tyr Asp Ala
Gln Tyr Glu Gly
Gln Tyr Gly Glu
Arg Cys Met Ser
Arg Cys Ser Met
Arg Met Cys Ser
Arg Met Ser Cys
Arg Ser Cys Met
Arg Ser Met Cys
Ser Cys Met Arg
Ser Cys Arg Met
Ser Asp Phe Gln
Ser Asp Gln Phe
Ser Glu Phe Asn
Ser Glu Asn Phe
Ser Phe Asp Gln
Ser Phe Glu Asn
Ser Phe Asn Glu
Ser Phe Gln Asp
Ser Met Cys Arg
Ser Met Arg Cys
Ser Asn Glu Phe
Ser Asn Phe Glu
Ser Gln Asp Phe
Ser Gln Phe Asp
Ser Arg Cys Met
Ser Arg Met Cys
Thr Asp Phe Asn
Thr Asp Asn Phe
Thr Phe Asp Asn
Thr Phe Asn Asp
Thr Asn Asp Phe
Tyr Ala Asp Gln
Tyr Ala Glu Asn
Tyr Ala Asn Glu
Tyr Ala Gln Asp
Tyr Asp Ala Gln
Tyr Asp Gln Ala
Tyr Glu Ala Asn
Tyr Glu Gly Gln
Tyr Glu Asn Ala
Tyr Glu Gln Gly
Tyr Gly Glu Gln
Tyr Gly Gln Glu
Tyr Asn Ala Glu
Tyr Asn Glu Ala
Tyr Gln Ala Asp
Tyr Gln Asp Ala
Tyr Gln Glu Gly
Tyr Gln Gly Glu
2-Methyl-5-[(4-phenyl-1-piperazinyl)-(3,4,5-trimethoxyphenyl)methyl]-6-thiazolo[3,2-b][1,2,4]triazolol
(2S,3R,4S,5S,6R)-2-[(1S,2R,5S,6S)-2,6-dihydroxy-3-(hydroxymethyl)-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohex-3-en-1-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Isometamidium chloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
N-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-2-[[2-(1-oxoisoquinolin-2-yl)acetyl]amino]acetamide
1-[[2-(3-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-3-piperidinecarboxamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(2R,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5S,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
4-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
4-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
2-[(2S,5R,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5S,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2S,5S,6S)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5R,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2S,5R,6R)-5-[[(2,5-difluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
4-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
4-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-[(1-methyl-4-imidazolyl)sulfonyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide
(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-12-(2-methoxyacetyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-12-(2-methoxyacetyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
Anti-inflammatory agent 35
Anti-inflammatory agent 35 (compound 5a27) is an orally active curcumin analogue with anti-inflammatory activity. Anti-inflammatory agent 35 blocks mitogen-activated protein kinase (MAPK) signaling and p65 nuclear translocation of NF-kB. Anti-inflammatory agent 35 also inhibits yellow neutrophil infiltration and pro-inflammatory cytokine production. Anti-inflammatory agent 35 significantly attenuates lipopolysaccharide (LPS)-induced acute lung injury (ALI) in vivo[1].